SECOND SUPPLEMENTAL FRAMEWORK AGREEMENT IN RELATION TOSecond Supplemental Framework Agreement • October 21st, 2022
Contract Type FiledOctober 21st, 2022This announcement is made by Touyun Biotech Group Limited (the ‘‘Company’’) pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ‘‘Listing Rules’’) and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Future Ordinance (Chapter 571 of the Laws of Hong Kong).